about
TPO receptor agonist for chronic idiopathic thrombocytopenic purpuraTPO receptor agonist for chronic idiopathic thrombocytopenic purpuraLong-term safety and efficacy of romiplostim for treatment of immune thrombocytopeniaApproaches to Managing Autoimmune Cytopenias in Novel Immunological Disorders with Genetic Underpinnings Like Autoimmune Lymphoproliferative SyndromeContemporary management of primary immune thrombocytopenia in adultsLaparoscopic splenectomy for primary immune thrombocytopenia: Current status and challengesAutoimmunity in common variable immunodeficiency: epidemiology, pathophysiology and management.Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Ischemic stroke associated with immune thrombocytopenia.Management of patients with refractory immune thrombocytopenic purpura.Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective.Rituximab in the treatment of autoimmune haematological disorders.Therapeutic implications of T-cell clonopathy of unknown significance in chronic immune thrombocytopenic purpura.Efficacy and safety of Privigen, a novel liquid intravenous immunoglobulin formulation, in adolescent and adult patients with chronic immune thrombocytopenic purpura.Immune thrombocytopenia in pregnancyPatients' benefit-risk preferences for chronic idiopathic thrombocytopenic purpura therapies.Management of chronic immune thrombocytopenic purpura: targeting insufficient megakaryopoiesis as a novel therapeutic principleTreatment options for chronic refractory idiopathic thrombocytopenic purpura in adults: focus on romiplostim and eltrombopag.Durability and factors associated with long term response after splenectomy for primary immune thrombocytopenia (ITP) and outcome of relapsed or refractory patients.Long-term management of chronic immune thrombocytopenic purpura in adults.Eltrombopag for the treatment of idiopathic thrombocytopenic purpura.Pathophysiology and therapeutic options in primary immune thrombocytopenia.Romiplostim in children with chronic refractory ITP: randomized placebo controlled study.Current treatment options for primary immune thrombocytopenia.Fatigue in adult patients with primary immune thrombocytopenia.The experience of Flebogammadif® in primary immune thrombocytopenia.Can thrombelastography be a new tool to assess bleeding risk in patients with idiopathic thrombocytopenic purpura?Eltrombopag for the treatment of immune thrombocytopenia.Severe isolated thrombocytopenia after clopidogrel and pentoxifylline therapy: a case report.Thrombopoietin receptor agonist therapy in primary immune thrombocytopenia is associated with bone marrow hypercellularity and mild reticulin fibrosis but not other stromal abnormalities.The scintigraphic index spleen/liver at 30 minutes predicts the success of splenectomy in persistent and chronic primary immune thrombocytopenia.Cognitive symptoms are common in immune thrombocytopenia and associate with autonomic symptom burden.Patient-reported treatment burden of chronic immune thrombocytopenia therapies.Eltrombopag: the emerging evidence of its therapeutic value in thrombocytopeniaDiagnosis and management of maternal thrombocytopenia in pregnancy.H pylori-induced thrombocytopenia in a Caucasian female: a case report.Prolonged remission from eltrombopag in chronic refractory idiopathic thrombocytopenic purpura.Perinatal outcome of pregnancies complicated by immune thrombocytopenia.Low expression of FCGRIIB in macrophages of immune thrombocytopenia-affected individuals.Repeated short-term use of eltrombopag in patients with chronic immune thrombocytopenia (ITP).
P2860
Q24235481-2E083093-C559-4485-A667-B45716D29228Q24241275-73D1CE25-C81E-46A9-A7DB-52AEB5CEA2D5Q26745753-FAA984BD-E0B7-4BCC-81A8-172188B5354EQ26799956-42E812FC-1A1A-482C-92B6-678BD080BACEQ26853680-69990F8F-47A2-4982-801B-84F88FF6D81AQ28066579-5D04B1D2-B393-4301-9C99-14091B36A19DQ30245322-46F587B2-D28E-4E31-852F-CEC2CFC4601BQ30276550-88C7A2D5-F9BA-4362-90A4-B933BA63D15DQ30868478-870515D4-BE45-4002-BA80-2FAAEE096BA6Q33372113-F48DBBF5-91B7-41D3-8CD9-45E924FB74BFQ33378585-F163E218-E95B-4AC9-9B21-180B8ACD216CQ33378854-852C3CD2-440F-4527-9056-8FE6466E43E2Q33383399-9C1DFCD9-A7EC-4370-9051-018C690634D4Q33385549-804C424A-E6CA-4064-81E8-D049D8C38EDAQ33387170-1BDD062E-664B-4982-9B56-2AB1E3C7F53FQ33388078-D18EA447-8460-496F-A470-11AC72FF486BQ33390001-41E4ED86-0814-435B-8E5E-51B9C3492892Q33390380-68AEA51F-51DC-4971-8282-33DC90B73F3FQ33392406-A61367CA-07D0-4BB5-A138-6867074C5EAAQ33392610-4934EA23-6DF7-46DA-9086-0391AD479864Q33392852-AC023093-9C6E-465A-806F-795699E91B62Q33393732-7D92D401-BE01-44DF-B54F-861D2A225268Q33394122-D2DF9FA9-9E40-485E-A650-3067663FAB26Q33394149-3FDEFDB7-FDB7-4A96-91D6-9583F39DEDEDQ33394156-91297AF3-F78B-47AB-A412-9315A3AEDDE2Q33394796-4699178E-82BB-4A8B-9810-8D3B00C99AC7Q33395255-A39DE662-BB70-4090-A32B-28B6CEA2635BQ33395776-9392BC61-64F9-4FE0-B410-218227F4C9C9Q33396075-5D99F0D0-69CE-40B6-859E-848986A7522DQ33396730-373A3986-00FA-4DCA-AA1A-432A10FE9E07Q33397351-1AA5063D-153A-4375-9958-C654D87A7055Q33397931-4E987268-F2E6-4AEE-BCA0-52894F906FB6Q33400348-09E852DF-53DF-400E-942E-B6EC9538AE56Q33400722-16A2819F-9333-40F1-92BB-D444911315D4Q33401045-1434C7AC-1E96-4ABB-90AB-AE66736004C1Q33402328-0E3AC8BD-FAB1-4038-98EA-DAD58E08FFE1Q33402617-C795FC88-B071-4EA1-B195-7DF1A00CBB5EQ33403464-B37163D1-DB34-46CC-9225-CC31C32EAE2BQ33403755-6ADF2D3E-AE1B-46C0-925A-90C56ECD48A3Q33405057-EB3A5DA0-4420-422B-977A-E26EB5E78DC8
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
How I treat idiopathic thrombocytopenic purpura (ITP).
@ast
How I treat idiopathic thrombocytopenic purpura (ITP).
@en
type
label
How I treat idiopathic thrombocytopenic purpura (ITP).
@ast
How I treat idiopathic thrombocytopenic purpura (ITP).
@en
prefLabel
How I treat idiopathic thrombocytopenic purpura (ITP).
@ast
How I treat idiopathic thrombocytopenic purpura (ITP).
@en
P1433
P1476
How I treat idiopathic thrombocytopenic purpura (ITP).
@en
P2093
Douglas B Cines
P304
P356
10.1182/BLOOD-2004-12-4598
P407
P577
2005-06-07T00:00:00Z